STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON
Report
- Report Number
- 3009784280-2021-00055
- Event Type
- Death
- Date Received
- June 3, 2021
- Date of Event
- August 9, 2018
- Report Date
- May 12, 2021
- Manufacturer
- SPECTRANETICS
- Product Code
- ONU
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
BLOCK H6: ADDED CODE 1802 (DEATH). ALTHOUGH THE CAUSE OF DEATH IS UNRELATED TO THE STUDY DEVICE, DEATH IS LISTED IN THE IFU AS A POTENTIAL COMPLICATIONS/ ADVERSE EVENTS. COMPONENT CODES INTENTIONALLY LEFT BLANK. NO DEVICE MALFUNCTION WAS REPORTED DURING THE INDEX PROCEDURE.
THE PATIENT'S ETHNICITY AND RACE ARE UNKNOWN. THIS INFORMATION WAS NOT AVAILABLE FROM THE FACILITY. THE PATIENT'S CAUSE OF DEATH WAS UNRELATED TO THE STUDY DEVICE OR PROCEDURE. THIS IS BEING REPORTED AS A FOLLOW-UP TO THE CLINICAL REGISTRY. PATIENT INFORMATION REGARDING RELEVANT TESTS/LABORATORY DATA IS UNKNOWN. THIS INFORMATION WAS NOT AVAILABLE FROM THE FACILITY. REPORT SOURCE: FOREIGN- (B)(6)/ STUDY NAME: (B)(6): PATIENT ID #(B)(6). PMA NUMBER IS NOT APPLICABLE. THE DEVICE IS A COMMERCIAL PRODUCT WITH A CE MARK THAT WAS USED AS PART OF A CLINICAL REGISTRY. DURING THE INDEX PROCEDURE, THE PRODUCT WORKED AS INTENDED AND THE DEVICE WAS DISCARDED, THUS NO PRODUCT EVALUATION WAS REQUIRED. (B)(4).
IT WAS REPORTED THROUGH A CLINICAL REGISTRY THAT DURING THE INDEX PROCEDURE ON (B)(6) 2018, A STELLAREX CATHETER WAS USED TO TREAT THE TARGET LESION OF THE RIGHT MID SFA. APPROXIMATELY 31 MONTHS POST INDEX PROCEDURE, THE PATIENT EXPIRED DUE TO GANGRENE, PERIPHERAL VASCULAR DISEASE, COLON CANCER, DIABETES MELLITIS TYPE II, FRAILTY, AND COPD ON (B)(6) 2021. THE PHYSICIAN INDICATED THIS IS NOT RELATED TO THE STUDY DEVICE OR PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 823451 | STELLAREX 0.035 OTW DRUG-COATED ANGIOPLASTY BALLOON | DCB PTA CATHETER | ONU | SPECTRANETICS | A35SX060120135 | FL518E22A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Other |